Categoría: Stem Cells
-
Stem Cell Therapeutics Corp. Announces Private Placement
Stem Cell Therapeutics is a biotechnology company from Calgary Canada that is developing a novel type of stem cell therapy: instead of administering stem cells, they give drugs that activate the patient’s own stem cells.
-
Stem cell therapy maker Aldagen files for IPO
The adult stem cell company Aldagen Inc, from Durham North Carolina announced today that it has filed a registration with the Securities Exchange Commission for an initial public offering with a potential value of $80.5 million.
-
‘Ethical’ stem cell crop boosted
Embryonic stem cells have attracted tremendous attention based on their ability to become any of the 220 types of cell in the human body.
-
Jaw bone created from stem cells
In a recent publication in the Proceedings of the National Academy of Sciences, researchers from Columbia University described the creation of a jaw bone (temporomandibular joint) made in the laboratory.
-
Scientists get closer to making safe patient-specific stem cells
In a study that appeared today in the Journal Cell Stem Cell, Dr Kevin Eggan’s group from Harvard reported a novel way of generating stem cells from adult cells.
-
Gilbert Stem Cell Research Programs are Making Healthcare History
Since those early studies which began in Phoenix Arizona in 2000, thousands of patients have been treated with their own stem cells for heart failure.
-
Breakthrough UW study may lead to cure for blindness in the future
Scientists at the University of Wisconsin-Madison announced today that they have succeeded in generating retinal cells from stem cells.
-
Fat-Derived Adult Stem Cells Targeted for Heart Disease Therapy
In yet another heart disease study, adult stem cells derived from adipose tissue are chosen as the most promising therapy.
-
Scientists Study Ways to Stimulate Endogenous Adult Stem Cells
Researchers at Johns Hopkins University are developing new therapies based upon methods of stimulating each person’s own naturally occurring endogenous adult stem cells.
-
BioTime Creates Asian Subsidiary
In collaboration with a Hong Kong company, the U.S. biotech company BioTime announces the formation of a new subsidiary, to be headquartered in China.